Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Aureus

Empirical coverage against 5. pneumoniae, L. pneumophila, H. influenzae, enteric GNB, 5. aureus Adult inpatient ICU (Pseudomonas is a concern)... [Pg.1056]

FIGURE 71-3. A. Conjunctival petechiae. (Copyright 2005 The Regents of the University California. All Rights Reserved. Used by permission.) B. Petechial rash on neck due to 5. aureus. (From Scheld W. In Atlas of Infectious Diseases ... [Pg.1092]

Hematogenous Neonates Prepubertal children Long bones (femur, tibia) Long bones (femur, tibia) Staphylococcus aureus,3 E. coli, group B streptococci 5. aureus Nafcillin and cefotaxime Nafcillin or cefazolin... [Pg.1179]

Without Vascular Insufficiency Adult (greater 50 years) Postoperative (e.g., hip fractures), soft-tissue infections 5. aureus Nafci 11 i n or cefazolin... [Pg.1179]

Fluoroquinolones Not approved by the United States Food and Drug Administration for use in children except for anthrax (ciprofloxacin). MRSA, methicillin-resistant 5. aureus MSSA, methicillin-sensitive 5. aureus. [Pg.1182]

Hospita k residentia 1 Mouth anaerobes, 5. aureus, Clindamycin, ticarcillin-clavulanate,... [Pg.487]

Nosocomial pneumonia Gram-negative bacilli (such as K pneumoniae, Enterobacter spp.. Pseudomonas aeruginosa), 5. aureus Pi peraci 11 i n-tazo bacta rr carbapenem,e or extended-speclrum cephalosporin plus aminoglycoside, fluoroquinolone ... [Pg.487]

Head and neck cancer resection Cardiothoracic surgery 5. aureus, streptococci oral anaerobes Clindamycin 600 mg at induction and every 8 hours x 2 more doses Add gentamicin for clean-contaminated procedures IA... [Pg.540]

Cardiac surgery S. aureus, Staphylococcus epidermidis, Corynebaderium Cefazolin 1 g every 8 hours x 48 hours Patients >80 kg should receive 2 g of cefazolin instead in areas with high prevalence of 5. aureus resistance, vancomycin should be considered IA... [Pg.540]

Hip fracture repair 5. aureus, S. epidermidis Cefazolin 1 gx 1 preoperatively, then every 8 hours for 48 hours Compound fractures are treated as if infection is presumed IA... [Pg.541]

Fig. 4 Identification of alkyne-tagged P-lactone probes that target ClpP in S. aureus using click-chemistry, in-gel fluorescence and mass spectrometry. Subsequently, lead compounds were administered to 5. aureus and changes to the global bacterial proteome monitored. Particularly, changes to the levels of haemolysis and proteolysis enzymes (haemolysins, proteases, lipases and... Fig. 4 Identification of alkyne-tagged P-lactone probes that target ClpP in S. aureus using click-chemistry, in-gel fluorescence and mass spectrometry. Subsequently, lead compounds were administered to 5. aureus and changes to the global bacterial proteome monitored. Particularly, changes to the levels of haemolysis and proteolysis enzymes (haemolysins, proteases, lipases and...
Forsgren, A., and Sjoquist, J. (1966). Protein A from 5. aureus. I. Pseudo-immune reaction with human gamma-globulin. ]. Immunol. 97, 822-827. [Pg.622]

Inducible resistance to high levels of vancomycin in enterococci is mediated by transposon Tn 1546 or related transposons [262, 263]. The transposition of Tn 1546 into plasmids with a broad host range or into con-jugative transposons would enable resistance to spread to 5. aureus which can exchange genetic information with enterococci [260]. Plasmid-mediated resistance to vancomycin has been successfully conjugated, in laboratory experiments, from enterococci to S. aureus, provided that erythromycin (6) and not vancomycin was used as the selective agent [265], It was only a question of time before such an event was shown to occur clinically [266, 267] and vancomycin resistance has now been found in an MRSA strain [268]. The seriousness of this cannot be over-emphasized. [Pg.174]

Cerebrospinal fluid shunt procedures 5. aureus, S. epidermidis Cefazolin 1 g every 8 hours x 3 doses or ceftriaxone 2 gx 1 No agents have been shown to be better than cefazolin in randomized comparative trials. lA... [Pg.528]

The T and V indicate expected tryptic and 5. aureus V8 protease peptides, respectively. [Pg.846]

Fig. 6. Transmembrane arrangement of the a- and /3-polypeptides of the B880 antenna complex from Rs. rubrum. The hydrophobic domain is located within the hydrocarbon-tail region of the membrane the N- and C-terminal domains are at or near the membrane surface at the cytoplasmic or periplasmic side, respectively. PK, proteinase K CH, chymotrypsin TR, trypsin SA, 5. aureus protease. Fig. 6. Transmembrane arrangement of the a- and /3-polypeptides of the B880 antenna complex from Rs. rubrum. The hydrophobic domain is located within the hydrocarbon-tail region of the membrane the N- and C-terminal domains are at or near the membrane surface at the cytoplasmic or periplasmic side, respectively. PK, proteinase K CH, chymotrypsin TR, trypsin SA, 5. aureus protease.
An important mechanism of acqnired resistance to cephalosporins is drug inactivation by P-lactamases to which the cephalosporins have variable snsceptibility. For example, the P-lactamases produced by S. aureus are considered tme penicillinases and do not affect the cephalosporins. Thus the cephalosporins are nsnally active against penicillinase-producing 5. aureus. In contrast, gram-negative bacteria produce p-lactamases that inactivate many of the cephalosporins. [Pg.183]

All cephalosporins lack activity against enterococci, methiciUin-resistant 5. aureus and 5. epidermtdts, and Acinetobacter species. IV, intravenous IM, intramuscular PO, oral. [Pg.184]

Staphylococci Positive Cocci Central Round or oval Yellow- white Minimal 5. epidermidis. rapid 5. aureus. less rapid... [Pg.521]

Protein A present in the cell wall of Staphylococcus aureus is a marker probe for the Fc portion of IgG-1, -2 and -4. Thus, a one step purification of protein A from extracts of 5. aureus was achieved using IgG coupled to Sepharose 4B affinity media [146]. The preparations obtained were pure as judged by electrophoresis. Conversely, affinity... [Pg.129]

Determine the titer of immunoglobulin solution for the microorganism to be utilized in the assay. Select a dilution of the immunoglobulin that does not cause aggregation of the particles. If 5. aureus or E. coli Bio-particles from Molecular Probes are used, follow the directions provided by the manufacturer. [Pg.254]


See other pages where Aureus is mentioned: [Pg.254]    [Pg.1179]    [Pg.1180]    [Pg.1186]    [Pg.523]    [Pg.240]    [Pg.688]    [Pg.174]    [Pg.153]    [Pg.154]    [Pg.182]    [Pg.169]    [Pg.173]    [Pg.186]    [Pg.173]    [Pg.527]    [Pg.237]    [Pg.391]    [Pg.439]    [Pg.447]    [Pg.447]    [Pg.449]    [Pg.405]    [Pg.252]    [Pg.117]   
See also in sourсe #XX -- [ Pg.369 , Pg.371 ]

See also in sourсe #XX -- [ Pg.261 ]

See also in sourсe #XX -- [ Pg.3 , Pg.164 , Pg.176 , Pg.344 , Pg.391 , Pg.393 , Pg.394 , Pg.395 , Pg.396 , Pg.397 , Pg.398 , Pg.399 ]




SEARCH



Allergic rhinitis, Staphylococcus aureus

Amino acids Staph, aureus

Antibiotics Staph, aureus

Antibiotics against Staphylococcus aureus

Antimicrobial activity against Staphylococcus aureus

Arachniotus aureus

Aspergillus aureus

Aureus Pharma

Aureus database

Bacitracin aureus

Biological Activity Staphylococcus aureus

Canis aureus

Chloramphenicol Staph, aureus

Chlorhexidine Staphylococcus aureus

Chromagar staph aureus

Ciprofloxacin aureus

Gentamicin Staphylococcus aureus

Infection Staphylococcus aureus

Maier Tripus Aureus

Meningitis Staphylococcus aureus

Methacillin-resistant staphylococcus aureus

Methacillin-resistant staphylococcus aureus MRSA)

Methicilin-resistant Staphylococcus aureus

Methicillin resistant Staph. Aureus

Methicillin resistant Staphyloccus aureus

Methicillin resistant Staphyloccus aureus MRSA)

Methicillin resistant Staphylococcus aureus MRSA) infection

Methicillin-resistant 5. aureus

Methicillin-resistant S. aureus

Methicillin-resistant Staphylococcus aureus MRSA)

Methicillin-resistant Staphylococcus aureus strain

Methicillin-sensitive 5. aureus

Methicillin-sensitive S. aureus

Methicillin-susceptible Staphylococcus aureus

Methicillin-susceptible Staphylococcus aureus MSSA)

Meticillin resistant Staphylococcus aureus

Micrococcus aureus

Multiple-resistant Staphylococcus aureus

Multiple-resistant Staphylococcus aureus MRSA)

Neomycin aureus

Nicotinic acid aureus

Oreochromis aureus

Organisms Staphylococcus aureus

Penicillin Staph, aureus

Penicillin-resistant Staphylococcus aureus

Peptidoglycan Staphylococcus aureus

Peptidoglycans Staphylococcus aureus

Phaseolus aureus

Phaseolus aureus vulgaris

Pore Staphylococcus aureus

Protein A of Staphylococcus aureus

Purines Staph, aureus

Pyrimidines Staph, aureus

Rapid microbiology Staphylococcus aureus

Resistant Staphylococcus aureus

Rifampin aureus

S. aureus

S. aureus vaccine

Scindapsus aureus

Senecio aureus

Spoilage microorganisms Staphylococcus aureus

Staph, aureus

Staphilococus aureus

Staphlococcus aureus

Staphyllococcus aureus

Staphyllococcus aureus minimal inhibitory concentration

Staphyloccocus aureus

Staphyloccus aureus

Staphylococcal aureus

Staphylococcus aureus

Staphylococcus aureus 5-lysin

Staphylococcus aureus 5. epidermidis

Staphylococcus aureus Subject

Staphylococcus aureus V8 protease

Staphylococcus aureus a-toxin

Staphylococcus aureus amino acid requirements

Staphylococcus aureus and

Staphylococcus aureus and Klebsiella pneumoniae

Staphylococcus aureus antibacterial activity against

Staphylococcus aureus antibacterial properties

Staphylococcus aureus antibiotic therapy

Staphylococcus aureus antibiotics active against

Staphylococcus aureus antifungal activity against

Staphylococcus aureus antimicrobial therapy

Staphylococcus aureus antimicrobials effective against

Staphylococcus aureus attachment

Staphylococcus aureus bacitracin resistance

Staphylococcus aureus biological properties

Staphylococcus aureus chemical properties

Staphylococcus aureus community-acquired

Staphylococcus aureus cystic fibrosis infections

Staphylococcus aureus discovery

Staphylococcus aureus diseases caused

Staphylococcus aureus drug resistance

Staphylococcus aureus effect of antibiotics

Staphylococcus aureus enterotoxin

Staphylococcus aureus enterotoxin B

Staphylococcus aureus enumeration

Staphylococcus aureus erythromycin resistance

Staphylococcus aureus expression regulation

Staphylococcus aureus gene transfer

Staphylococcus aureus gram-positive

Staphylococcus aureus growth

Staphylococcus aureus illness from

Staphylococcus aureus infection methicillin-resistant

Staphylococcus aureus infection resistance

Staphylococcus aureus infection treatment

Staphylococcus aureus infections vancomycin-resistant

Staphylococcus aureus inhibition

Staphylococcus aureus inhibitors

Staphylococcus aureus lipase

Staphylococcus aureus lung abscess

Staphylococcus aureus lysis

Staphylococcus aureus metal activation

Staphylococcus aureus methicillin-resistant

Staphylococcus aureus minimal inhibitory concentration

Staphylococcus aureus molecular properties

Staphylococcus aureus multiple drug resistance

Staphylococcus aureus nasal carriage

Staphylococcus aureus normal flora

Staphylococcus aureus operators

Staphylococcus aureus penicillin resistance

Staphylococcus aureus phage

Staphylococcus aureus pigment

Staphylococcus aureus pneumonia

Staphylococcus aureus products

Staphylococcus aureus protein

Staphylococcus aureus protein A

Staphylococcus aureus protein synthesis

Staphylococcus aureus purification

Staphylococcus aureus quinolone resistance

Staphylococcus aureus rates

Staphylococcus aureus sequence

Staphylococcus aureus skin infections

Staphylococcus aureus sputum cultures

Staphylococcus aureus stages

Staphylococcus aureus substrates

Staphylococcus aureus teichoic acid from

Staphylococcus aureus tetracycline-resistant

Staphylococcus aureus total synthesis

Staphylococcus aureus toxic shock syndrome toxin

Staphylococcus aureus transduction

Staphylococcus aureus transmission

Staphylococcus aureus treatment

Staphylococcus aureus typing

Staphylococcus aureus vancomycin-intermediate

Staphylococcus aureus vancomycin-resistant

Staphylococcus aureus virulent strains

Staphylococcus aureus, Pore-forming

Staphylococcus aureus, colonization

Staphylococcus aureus, cytochromes

Staphylococcus aureus, food poisoning

Staphylococcus aureus, food poisoning caused

Staphylococcus aureus, intrinsic resistance

Staphylococcus aureus, methicillinresistant

Staphylococcus aureus, penicillin

Staphylococcus aureus, protein produced

Staphylococcus aureus, sterol

Staphylococcus pyogenes aureus

Staphylococcus species aureus

Staphylokinase aureus

Sterilization Staphylococcus aureus

Straphylococcus aureus

Streptococcus aureus

Streptomyces aureus

Sugar aureus

Test methods Staphylococcus aureus showing

Vaccination, Staphylococcus aureus

Vancomycin Staphylococcus aureus

Vancomycin aureus

Vancomycin reduced Staphylococcus aureus

Water Staphylococcus aureus growth

X. aureus

© 2024 chempedia.info